A COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS OF FIDAXOMICIN FOR TREATING CLOSTRIDIUM DIFFICILE PATIENTS IN GERMANY

被引：1
|
作者：
Watt, M. [1 ]
McCrea, C. [2 ]
Johal, S. [3 ]
Posnett, J. [2 ]
Nazir, J. [1 ]
机构：
[1] Astellas, Chertsey, Surrey, England
[2] Heron Commercializat, London, England
[3] Parexel Int, London, England
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 03期
关键词：
D O I：
10.1016/j.jval.2015.03.1357
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN33
引用
收藏
页码：A233 / A233
页数：1
相关论文
共 50 条
  • [1] A cost-effectiveness and budget impact analysis of first-line fidaxomicin for patients with Clostridium difficile infection (CDI) in Germany
    Maureen Watt
    Charles McCrea
    Sukhvinder Johal
    John Posnett
    Jameel Nazir
    Infection, 2016, 44 : 599 - 606
  • [2] A cost-effectiveness and budget impact analysis of first-line fidaxomicin for patients with Clostridium difficile infection (CDI) in Germany
    Watt, Maureen
    McCrea, Charles
    Johal, Sukhvinder
    Posnett, John
    Nazir, Jameel
    INFECTION, 2016, 44 (05) : 599 - 606
  • [3] Cost-Effectiveness of Fidaxomicin for Clostridium difficile Treatment
    Simon, Matthew S.
    CLINICAL INFECTIOUS DISEASES, 2014, 58 (04)
  • [4] COST-EFFECTIVENESS ANALYSIS OF FIDAXOMICIN FOR CLOSTRIDIUM DIFFICILE INFECTION IN JAPAN
    Okumura, H.
    Ueyama, M.
    Shoji, S.
    English, M.
    VALUE IN HEALTH, 2019, 22 : S200 - S200
  • [5] Cost-effectiveness analysis of fidaxomicin versus vancomycin in Clostridium difficile infection
    Nathwani, Dilip
    Cornely, Oliver A.
    Van Engen, Anke K.
    Odufowora-Sita, Olatunji
    Retsa, Peny
    Odeyemi, Isaac A. O.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (11) : 2901 - 2912
  • [6] Cost-effectiveness analysis of fidaxomicin for the treatment of Clostridioides (Clostridium) difficile infection in Japan
    Okumura, Hiroyuki
    Ueyama, Maki
    Shoji, Shingo
    English, Marci
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2020, 26 (06) : 611 - 618
  • [7] COST-EFFECTIVENESS OF FIDAXOMICIN THERAPY FOR CLOSTRIDIUM DIFFICILE INFECTION IN HUNGARY
    Brodszky, V
    Strbak, B.
    Baji, P.
    Pentek, M.
    Gulacsi, L.
    VALUE IN HEALTH, 2014, 17 (07) : A675 - A675
  • [8] COST-EFFECTIVENESS OF FIDAXOMICIN VERSUS VANCOMYCIN AND METRONIDAZOLE IN PATIENTS WITH CLOSTRIDIUM DIFFICILE INFECTION IN SPAIN
    Watt, M.
    de Nigris, E.
    McCrea, C.
    VALUE IN HEALTH, 2017, 20 (09) : A784 - A784
  • [9] COST-EFFECTIVENESS OF FIDAXOMICIN FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION (CDI) IN SWEDEN
    Van Engen, A.
    Lie, X.
    Noren, T.
    Nordling, S.
    Norgaard, K.
    VALUE IN HEALTH, 2014, 17 (07) : A673 - A674
  • [10] Cost-effectiveness analysis on the use of fidaxomicin and vancomycin to treat Clostridium difficile infection in France
    Watt, Maureen
    Dinh, Aur Elien
    Le Monnier, Alban
    Tilleul, Patrick
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (07) : 678 - 686
12345